The Asia Pacific Glucosamine Market would witness market growth of 5.4% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 32,449.00 Tonnes, showcasing a growth of 4.6% (2019-2022).
It is widely used to maintain and improve joint health, particularly osteoarthritis. Osteoarthritis is a degenerative joint disorder characterized by the breakdown of cartilage, and this is believed to contribute to the repair and maintenance of cartilage. This has gained popularity among athletes and fitness enthusiasts as a preventive measure against joint stress and injuries. The compound promotes joint flexibility, reduces inflammation, and supports overall joint health, enhancing athletic performance and recovery. It is frequently included in sports nutrition products such as energy bars, drinks, and supplements to cater to individuals' unique joint health needs in rigorous physical activities.
It is available in various supplement formats, including glucosamine sulphate, hydrochloride, and combinations with other joint-supporting ingredients. This diversity allows consumers to choose formulations that align with their preferences and health needs. Integrating this into functional foods and beverages provides an alternative way for individuals to incorporate this compound into their daily diets. This trend aligns with the broader market shift toward food-based solutions for health and wellness. This is increasingly being embraced as part of a holistic approach to wellness.
As per the U.S. Department of Agriculture, the total value of retail food and beverage (F & B) sales in Japan increased by 1.5 percent to $474.13 billion in 2020, compared to $466.97 billion in 2019. Japanese consumers increasingly seek functional foods and nutraceuticals that provide health benefits beyond basic nutrition. The Japanese has witnessed an increased focus on preventive health, with consumers proactively seeking products that contribute to overall well-being. Japan has a significant aging population facing joint health concerns, creating a demand for solutions to support joint function. Thus, due to the above-mentioned factors, the market will grow significantly in this region.
The China market dominated the Asia Pacific Glucosamine Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $156.2 Million by 2030. The Japan market is registering a CAGR of 4.7% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 6.1% during (2023 - 2030).
Based on Application, the market is segmented into Supplement, Food & Beverage, and Others. Based on Product, the market is segmented into Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
It is widely used to maintain and improve joint health, particularly osteoarthritis. Osteoarthritis is a degenerative joint disorder characterized by the breakdown of cartilage, and this is believed to contribute to the repair and maintenance of cartilage. This has gained popularity among athletes and fitness enthusiasts as a preventive measure against joint stress and injuries. The compound promotes joint flexibility, reduces inflammation, and supports overall joint health, enhancing athletic performance and recovery. It is frequently included in sports nutrition products such as energy bars, drinks, and supplements to cater to individuals' unique joint health needs in rigorous physical activities.
It is available in various supplement formats, including glucosamine sulphate, hydrochloride, and combinations with other joint-supporting ingredients. This diversity allows consumers to choose formulations that align with their preferences and health needs. Integrating this into functional foods and beverages provides an alternative way for individuals to incorporate this compound into their daily diets. This trend aligns with the broader market shift toward food-based solutions for health and wellness. This is increasingly being embraced as part of a holistic approach to wellness.
As per the U.S. Department of Agriculture, the total value of retail food and beverage (F & B) sales in Japan increased by 1.5 percent to $474.13 billion in 2020, compared to $466.97 billion in 2019. Japanese consumers increasingly seek functional foods and nutraceuticals that provide health benefits beyond basic nutrition. The Japanese has witnessed an increased focus on preventive health, with consumers proactively seeking products that contribute to overall well-being. Japan has a significant aging population facing joint health concerns, creating a demand for solutions to support joint function. Thus, due to the above-mentioned factors, the market will grow significantly in this region.
The China market dominated the Asia Pacific Glucosamine Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $156.2 Million by 2030. The Japan market is registering a CAGR of 4.7% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 6.1% during (2023 - 2030).
Based on Application, the market is segmented into Supplement, Food & Beverage, and Others. Based on Product, the market is segmented into Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Teva Pharmaceutical Industries Ltd.
- Laboratoires Expanscience S.A.
- Nutramax Laboratories, Inc.
- Amway Corporation
- CellMark AB
- Alfa Chemical Group
- Cargill, Incorporated
- Simply Supplements
- Reckitt Benckiser Group PLC
- Panvo Organics Pvt Ltd.
Market Report Segmentation
By Application (Volume, Tonnes, USD Billion, 2019-2030)- Supplement
- Food & Beverage
- Others
- Glucosamine Sulfate
- Glucosamine Hydrochloride
- N-acetyl Glucosamine
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Glucosamine Market by Application
Chapter 5. Asia Pacific Glucosamine Market by Product
Chapter 6. Asia Pacific Glucosamine Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Teva Pharmaceutical Industries Ltd.
- Laboratoires Expanscience S.A.
- Nutramax Laboratories, Inc.
- Amway Corporation
- CellMark AB
- Alfa Chemical Group
- Cargill, Incorporated
- Simply Supplements
- Reckitt Benckiser Group PLC
- Panvo Organics Pvt Ltd.
Methodology
LOADING...
